Cost-utility analysis of medication review with follow-up for cardiovascular outcomes: A microsimulation model

Antonio Ahumada-Canale, Constanza Vargas, Francisco Martinez-Mardones, José Cristian Plaza-Plaza, Shalom Benrimoj and Victoria Garcia-Cardenas

Health Policy, 2021, vol. 125, issue 11, 1406-1414

Abstract: Cardiovascular diseases are the leading cause of death. Pharmacist-led medication review with follow-up might be cost-effective preventing cardiovascular diseases.

Keywords: Cardiovascular system; Aged; Economics; Cost-effectiveness; Pharmacy; Drug Monitoring (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.sciencedirect.com/science/article/pii/S0168851021002372
Full text for ScienceDirect subscribers only

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:eee:hepoli:v:125:y:2021:i:11:p:1406-1414

DOI: 10.1016/j.healthpol.2021.09.004

Access Statistics for this article

Health Policy is currently edited by Katrien Kesteloot, Mia Defever and Irina Cleemput

More articles in Health Policy from Elsevier
Bibliographic data for series maintained by Catherine Liu () and ().